Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8265955 Methods and systems for assessing clinical outcomes

Patent 8265955 was granted and assigned to Theranos on September, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Theranos

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82659550

Patent Inventor Names

Ian Gibbons0

Elizabeth A. Holmes0

Seth Michelson0

Timothy Michael Kemp0

Date of Patent

September 11, 2012

Patent Application Number

132447620

Date Filed

September 26, 2011

Patent Citations Received

‌

US Patent 11710576 Method and system for computer-aided escalation in a digital health platform

‌

US Patent 11929156 Method and system for providing automated conversations

‌

US Patent D1038801 Reader device for an analyte detection system

‌

US Patent 11868384 Method and system for automatically determining responses in a messaging platform

‌

US Patent 11875895 Method and system for characterizing and/or treating poor sleep behavior

‌

US Patent 11908585 Method for modeling behavior and depression state

‌

US Patent 11769576 Method and system for improving care determination

Patent Primary Examiner

‌

Gerald J. O'Connor

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8265955 Methods and systems for assessing clinical outcomes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API